BGaze Solutions are science-based tools that have been developed and validated in collaboration with leading clinicians.
In diagnostics, our tools add objectivity, save time, and improve interaction with the patient and his or her environment.
The BGaze Clinic system includes advanced eye-tracking hardware to capture involuntary biomarker micro eye movement patterns (patented worldwide) that provide an even higher degree of objective diagnostic accuracy.
In therapy, our solutions deliver a substantial measurable reduction of key issues such as inattention, impulsivity and others, which can minimize the need for pharmaceutical treatment.
BGaze Solutions are the result of over 5 years of research & development by University of Barcelona spin-off company Braingaze. The Braingaze development team is led by Prof Dr Hans Supèr, a highly recognized neurobiologist with over 20 years of solid experience in investigating the hard neurobiological aspects of cognition and attention and their disorders. The Braingaze team collaborates closely with leading psychiatrists such as Dr José Alda (ADHD lead of the St Joan de Deu Specialized Pediatric Hospital in Spain).
Co-founder and CTO of Braingaze
Mental healthcare still mostly works with tools that reflect the technological capabilities of the previous millennium. This is unacceptable, given the huge impact that mental health has on the overall wellbeing of millions of persons and the huge impact that mental health has on the budgets for healthcare in developed countries. BGaze solutions bring mental healthcare into the digital, AI-empowered age leveraging patented and novel methods and combining those with practice-inspired protocols.